The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The role of CRF and CRF-related peptides in the dark side of addiction
Open accessAbstract
Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs, the development of dependence, and the manifestation of a negative emotional state when the drug is removed. Activation of brain stress systems is hypothesized to be a key element of the negative emotional state produced by dependence that drives drug-seeking through negative reinforcement mechanisms, defined as the “dark side” of addiction. The focus of the present review is on the role of corticotropin-releasing factor (CRF) and CRF-related peptides in the dark side of addiction. CRF is a key mediator of the hormonal, autonomic, and behavior responses to stressors. Emphasis is placed on the role of CRF in extrahypothalamic systems in the extended amygdala, including the central nucleus of the amygdala, bed nucleus of the stria terminalis, and a transition area in the shell of the nucleus accumbens, in the dark side of addiction. The urocortin/CRF2 systems have been less explored, but results suggest their role in the neuroadaptation associated with chronic drug use, sometimes in opposition to the effects produced by the CRF1 receptor. Compelling evidence argues that the CRF stress system, including its activation of the hypothalamic-pituitary-adrenal axis, plays a key role in engaging the transition to dependence and maintaining dependence once it is initiated. Understanding the role of the CRF systems in addiction not only provides insight into the neurobiology of the dark side of addiction, but also provides novel targets for identifying vulnerability to addiction and the treatment of addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRF (also termed corticotropin-releasing hormone, although the International Union of Pharmacology designation is CRF) was identified by classic techniques of peptide sequencing (Vale et al., 1981).”
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · cited 4×
“…seek and take the drug, (ii) loss of control in limiting intake, and (iii) emergence of a negative emotional state (e.g., dysphoria, anxiety, irritability) reflecting a motivational withdrawal syndrome when access to the drug is prevented (defined here as dependence) (Koob and Le Moal, 1997, 2008).”
InfluentialSelf-citationCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citationAllostasis: A New Paradigm to Explain Arousal Pathology
Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450
Cited by
Reward mechanisms in obesity: new insights and future directions
Kenny, P. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.016 · Cited by 748
Lopez-Quintero, C., Cobos, J. P. D. L., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.004 · Cited by 704
Stress and the HPA axis: role of glucocorticoids in alcohol dependence
Stephens, M. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.11 · Cited by 571
Volkow, N. D., Wang, G., Fowler, J. S., Tomasi, D., Telang, F., & Baler, R. (2010) · BioEssays · doi:10.1002/bies.201000042 · Cited by 532
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Self-citationEpigenetic inheritance of a cocaine-resistance phenotype
Vassoler, F. M., White, S. L., Schmidt, H. D., Sadri-Vakili, G., & Pierce, R. C. (2013) · Nature Neuroscience · doi:10.1038/nn.3280 · Cited by 418
Addiction and Brain Reward and Antireward Pathways
Gardner, E. L. (2011) · Advances in Psychosomatic Medicine · doi:10.1159/000324065 · Cited by 417
Sex differences in stress-related alcohol use
Peltier, M. R., Verplaetse, T. L., Mineur, Y. S., Petrakis, I. L., Cosgrove, K. P., Picciotto, M. R., & McKee, S. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100149 · Cited by 413
Neugebauer, V. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_13 · Cited by 399
Common cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382
Natural rewards, neuroplasticity, and non-drug addictions
Olsen, C. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.010 · Cited by 339
“…by lower tone of endogenous brain reward systems (Kenny, 2007; Wise, 2008; Bruijnzeel, 2009; Carlezon and Thomas, 2009) and is thought to regulate continued intake of drugs (and perhaps food) to relieve this state (a phenomenon known as negative reinforcement) (Cottone et al, 2008; Koob, 2010).”
BackgroundLang, R., Gundlach, A. L., Holmes, F. E., Hobson, S. A., Wynick, D., Hökfelt, T., & Kofler, B. (2015) · Pharmacological Reviews · doi:10.1124/pr.112.006536 · Cited by 327
The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective
Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.04.002 · Cited by 326
“Interestingly, CRF is involved in the onset/development of addiction (Koob, 2010; Sarnyai et al., 2001) but the data are not always consistent.”
BackgroundClarifying the roles of homeostasis and allostasis in physiological regulation.
Ramsay, D. S., & Woods, S. C. (2014) · Psychological Review · doi:10.1037/a0035942 · Cited by 320
Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis
Becker, J. B., Perry, A. N., & Westenbroek, C. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-14 · Cited by 317
Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307
“However , the research discussed above strongly implicates the extended amygdala as the source of CRF - containing neurons mediating both drug dependence and relapse ( for a complete review of this section , see Koob 2010 ) .”
Sex differences in the neurobiology of drug addiction
Bobzean, S. A. M., DeNobrega, A. K., & Perrotti, L. I. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.022 · Cited by 262
Functional heterogeneity in the bed nucleus of the stria terminalis
Gungor, N. Z., & Pare, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0856-16.2016 · Cited by 214
Goeldner, C., Lutz, P.-E., Darcq, E., Halter, T., Clesse, D., Ouagazzal, A.-M., & Kieffer, B. L. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.021 · Cited by 163
“This transient corticosterone increase could nonetheless contribute to the setting of depressive-like behavior during protracted abstinent, by triggering neuroadaptations in extrahypothalamic neuropeptidic stress circuits (3,24,25,62,63) or by influencing the serotoninergic tone, at pre-synaptic DR level or in forebra…”
BackgroundK. Garber, A., & H. Lustig, R. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104030146 · Cited by 143
Cippitelli, A., Damadzic, R., Singley, E., Thorsell, A., Ciccocioppo, R., Eskay, R. L., & Heilig, M. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.016 · Cited by 84
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84
Herman, M. A., Contet, C., & Roberto, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1267-16.2016 · Cited by 72
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Baiamonte, B. A., Valenza, M., Roltsch, E. A., Whitaker, A. M., Baynes, B. B., Sabino, V., & Gilpin, N. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.025 · Cited by 58
“Dysregulation of these brain CRF systems is heavily implicated in multiple psychiatric disorders including anxiety, depression, and alcohol and drug use disorders (Arborelius et al, 1999; Bale and Vale, 2004; Koob, 2010; Risbrough, 2006).”
BackgroundKnapp, D. J., Whitman, B. A., Wills, T. A., Angel, R. A., Overstreet, D. H., Criswell, H. E., Ming, Z., & Breese, G. R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.018 · Cited by 60
“CRF, in particular, appears to be integral in acute and persistent vulnerability to stress in alcohol dependence (Huang et al., 2010; Koob, 2010; Lowery and Thiele, 2010).”
BackgroundWang, L., Shen, M., Jiang, C., Ma, L., & Wang, F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw060 · Cited by 29
“When the activity of PV+ interneurons in the CeA was inhibited by the optogenetic approach during the morphine-withdrawal stage, we also explored the changes of CRH in the CeA, which is not only a key mediator of the behavior responses to stressors but also a related emotional hormone (Koob, 2010).”
BackgroundLevran, O., Peles, E., Randesi, M., Correa da Rosa, J., Shen, P.-H., Rotrosen, J., Adelson, M., & Kreek, M. J. (2018) · Pharmacogenomics · doi:10.2217/pgs-2017-0179 · Cited by 13
Metadata
- Authors
- Koob, G. F.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 1314
- Pages
- 3-14
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2005020429
- Cited by
- 290
- References
- 141
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.